Prefilled Syringes: Helium Leak Detection

Overview

Helium leak detection on prefilled syringes gives clients a quantitative, gas-leak-rate confirmation of syringe seal performance that is independent of the final drug formulation, making it a natural complement to the electrical and pressure-based methods used earlier in a program's development. The syringe is typically tested empty so that helium tracer gas, rather than the drug product, carries the leak signal. The method is focused on closure fitment and design and should be tested empty for design engineering purposes.

The syringe's two seal regions are treated as functionally separate tests: the needle-shield/crimp seal at the delivery end and the plunger/stopper seal at the fill end are each evaluated on their own population of samples, since the two interfaces have different geometries, different failure modes, and different achievable sensitivities in practice.

Sample & Container Type

• Prefilled syringes, including standard and long-barrel formats
• Tested empty or water/placebo-filled to isolate seal performance
• Needle-shield/crimp seal and plunger/stopper seal evaluated as separate tests

Product Class & Rheology

• Formulation-independent — helium tracer gas carries the signal, not the drug product
• Applicable across fill types since results transfer cleanly between formulations
• Most often used for final qualification or as an ongoing quality check across lots

General Test Method

Per ASTM F2391, the syringe (or a defined subset of it) is placed in a vacuum fixture that exposes only the seal of interest to the instrument, while helium is introduced or already present as tracer gas; the mass spectrometer reports an absolute leak rate against an appropriate acceptance limit, most often the same microbial-ingress-based Maximum Allowable Leakage Limit (MALL) framework used for vial and container testing generally.

Typical Findings & Sensitivity

The plunger/stopper seal typically performs very well against a MALL-level acceptance criterion — the large majority of units test near instrument background, with leak rates many orders of magnitude below a typical 1×10?6 mbar·L/sec limit. The needle-shield/crimp seal is a more variable region: while most units also pass comfortably, this interface is more prone to occasional, discrete outliers tied to specific assembly or component variation, and protocols are designed to flag such localized deviations for root-cause follow-up.

Frequently Asked Questions

1. Why test with helium if HVLD or vacuum decay already ran?

Helium leak detection provides an absolute, industry-recognized leak-rate number rather than a relative pass/fail signal, which is frequently what a client needs for final confirmation of a syringe closure system or for ongoing production-lot quality checks.

2. Does helium testing depend on the drug formulation?

Helium tracer gas testing can only be performed with an unfilled container, and testing is focused on closure design. Thus, testing with product or placebo is not necessary.

3. Which syringe seal shows more variability, stopper or shield?

The needle-shield/crimp seal is generally the more variable region, more prone to occasional discrete outliers tied to assembly or component variation, while the plunger/stopper seal performs consistently well against typical acceptance criteria.

4. What acceptance criteria are used for syringe helium testing?

Most programs use the same microbial-ingress-based Maximum Allowable Leakage Limit (MALL) framework applied to vial and container testing generally, commonly on the order of 1×10?6 mbar·L/sec.

5. Is helium leak testing destructive to the syringe?

No. The syringe or seal region of interest is evaluated intact inside a vacuum fixture without puncturing or opening the unit.

Why Clients Choose PTI for This Application

By evaluating the plunger/stopper and needle-shield/crimp seals as functionally separate tests, PTI gives clients seal-specific data rather than a single averaged result — combined with electrical (HVLD) and vacuum-decay work on the same syringe, this completes a three-technology toolkit clients can choose from, or combine, based on their formulation and regulatory needs.